Adaptyx Biosciences

Executive Summary

Adaptyx Biosciences is a Boston-based biotech developing an AI-driven wearable patch for continuous biomarker monitoring. The device analyzes interstitial fluid in real time using programmable molecular switches, providing lab-grade data. This platform aims to shift healthcare from episodic to proactive, data-driven care. Founded in 2020, the company leverages AI and drug delivery expertise to enable continuous molecular insights, potentially transforming chronic disease management and early diagnosis. While still in early stages, its novel approach addresses a critical need for real-time health monitoring.

Upcoming Catalysts (preview)

• Q3 2026Series A funding round60% success
• Q4 2026First-in-human study results50% success
• Q2 2027Strategic partnership with pharma or diagnostics company40% success